Xiaowu Liu

Title: Innovations in Coagulation Treatment by Xiaowu Liu

Introduction

Xiaowu Liu is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medicine, particularly in the area of coagulation treatment. His innovative work has led to the development of a unique antibody that targets coagulation factors, which is crucial for treating various medical conditions.

Latest Patents

Xiaowu Liu holds a patent for an anti-coagulation factor XI antibody. This patent discloses antibodies that bind to coagulation factor XI (FXI) and its activated form, factor XIa (FXIa). The patent also includes methods for preparing these antibodies and their use in treating and preventing conditions associated with thrombosis, such as complications arising from blood clots.

Career Highlights

Xiaowu Liu is associated with Shanghai Benemae Pharmaceutical Corporation, where he continues to advance his research and development efforts. His work is pivotal in creating therapeutic solutions that address coagulation-related health issues.

Collaborations

Xiaowu Liu collaborates with notable colleagues, including Wenyi Wang and Quan Yu. Their combined expertise enhances the research and development processes at their organization.

Conclusion

Xiaowu Liu's innovative contributions to the field of coagulation treatment exemplify the impact of targeted therapies in modern medicine. His work not only advances scientific knowledge but also holds the potential to improve patient outcomes significantly.